Endogenous apolipoprotein A-I stabilizes ATP-binding cassette transporter A1 and modulates Toll-like receptor 4 signaling in human macrophages

FASEB Journal

Volumn 26, Issue 5, 2012, Pages 2019-2030

  Mogilenko, Denis A ^a,b   Orlov, Sergey V ^a,b   Trulioff, Andrey S ^a   Ivanov, Andrey V ^c   Nagumanov, Vadim K ^b   Kudriavtsev, Igor V ^b   Shavva, Vladimir S ^b   Tanyanskiy, Dmitry A ^a   Perevozchikov, Andrej P ^a,b  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^c North West Regional Medical Center   (Russian Federation)

Author keywords

IL 1 ; Lipid rafts; LPS; NOS2; TNF

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; BACTERIUM LIPOPOLYSACCHARIDE; CD4 ANTIGEN; CD45 ANTIGEN; HIGH DENSITY LIPOPROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MEMBRANE PROTEIN; MESSENGER RNA; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL MEMBRANE; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LIPID RAFT; MACROPHAGE; MEMBRANE VESICLE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STABILITY; SIGNAL TRANSDUCTION;

ANIMALS; APOLIPOPROTEIN A-I; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

BACTERIA (MICROORGANISMS);

EID: 84860897602     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-193946     Document Type: Article

References (40)

1. Lewis, G. F., and Rader, D. J. (2005) New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ. Res. 96, 1221-1232 (Pubitemid 40962099)
2. Srivastava, R. A., and Srivastava, N. (2000) High density lipoprotein, apolipoprotein A-I, and coronary artery disease. Mol. Cell. Biochem. 209, 131-144 (Pubitemid 30451445)
3. Barter, P. J., and Rye, K. A. (1996) Molecular mechanisms of reverse cholesterol transport. Curr. Opin. Lipidol. 7, 82-87 (Pubitemid 26167021)
4. Hyka, N., Dayer, J. M., Modoux, C., Kohno, T., Edwards, C. K., Roux-Lombard, P., and Burger, D. (2001) Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 97, 2381-2389 (Pubitemid 32291485)
5. Barter, P. J., Nicholls, S., Rye, K. A., Anantharamaiah, G. M., Navab, M., and Fogelman, A. M. (2004) Antiinflammatory properties of HDL. Circ. Res. 95, 764-772 (Pubitemid 39390578)
6. Navab, M., Ananthramaiah, G. M., Reddy, S. T., Lenten, B. J. Van, Ansell, B. J., Fonarow, G. C., Vahabzadeh, K., Hama, S., Hough, G., Kamranpour, N., Berliner, J. A., Lusis, A. J., and Fogelman, A. M. (2004) The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J. Lipid Res. 45, 993-1007 (Pubitemid 38679495)
7. Epand, R. M., Stafford, A., Leon, B., Lock, P. E., Tytler, E. M., Segrest, J. P., and Anantharamaiah, G. M. (1994) HDL and apolipoprotein A-I protect erythrocytes against the generation of procoagulant activity. Arterioscler. Thromb. 14, 1775-1783
8. Eggerman, T. L., Hoeg, J. M., Meng, M. S., Tombragel, A., Bojanovski, D., and Brewer, H. B. J. (1991) Differential tissue-specific expression of human apoA-I and apoA-II. J. Lipid Res. 32, 821-828
9. Zannis, V. I., Cole, F. S., Jackson, C. L., Kurnit, D. M., and Karathanasis, S. K. (1985) Distribution of apolipoprotein A-I, C-II, C-III, and E mRNA in fetal human tissues. Time-dependent induction of apolipoprotein E mRNA by cultures of human monocyte-macrophages. Biochemistry 24, 4450-4455 (Pubitemid 15228451)
10. Nuño-González, P., Ruíz-Madrigal, B., Bastidas-Ramírez, B. E., Martínez-López, E., Segura, J. E., and Panduro, A. (2005) Expression of apolipoprotein AI mRNA in peripheral white blood cells of patients with alcoholic liver disease. Biochim. Biophys. Acta 1740, 350-356 (Pubitemid 40804747)
11. Martínez-López, E., Nuño-González, P., Ruiz-Madrigal, B., Rodríguez-Sancho, L. C., Hernández- Nazará, Z. H., Segura-Ortega, J. E., and Panduro, A. (2007) Apolipoprotein AI and apolipo-protein E mRNA expression in peripheral white blood cells from patients with orthotopic liver transplantation. Liver Int. 27, 930-937 (Pubitemid 47261946)
12. Major, A. S., Dove, D. E., Ishiguro, H., Su, Y. R., Brown, A. M., Liu, L., Carter, K. J., Linton, M. F., and Fazio, S. (2001) Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI(-/-) mice. Arterioscler. Thromb. Vasc. Biol. 21, 1790-1795 (Pubitemid 34223450)
13. Ishiguro, H., Yoshida, H., Major, A. S., Zhu, T., Babaev, V. R., Linton, M. F., and Fazio, S. (2001) Retrovirus-mediated expression of apolipoprotein A-I in the macrophage protects against atherosclerosis in vivo. J. Biol. Chem. 276, 36742-36748
14. Su, Y. R., Blakemore, J. L., Zhang, Y., Linton, M. F., and Fazio, S. (2008) Lentiviral transduction of apoAI into hematopoietic progenitor cells and macrophages: applications to cell therapy of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 28, 1439 -1446
15. McVicar, J. P., Kunitake, S. T., Hamilton, R. L., and Kane, J. P. (1984) Characteristics of human lipoproteins isolated by selected-affinity immunosorption of apolipoprotein A-I. Proc. Natl. Acad. Sci. U. S. A. 81, 1356-1360 (Pubitemid 14173468)
16. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Resource Council (1996) Guide for the Care and Use of Laboratory Animals, National Academy Press, Washington, DC
17. Mogilenko, D. A., Dizhe, E. B., Shavva, V. S., Lapikov, I. A., Orlov, S. V., and Perevozchikov, A. P. (2009) Role of the nuclear receptors HNF4 alpha, PPAR alpha, and LXRs in the TNF alpha-mediated inhibition of human apolipoprotein A-I gene expression in HepG2 cells. Biochemistry 48, 11950 -11960
18. Mogilenko, D. A., Shavva, V. S., Dizhe, E. B., Orlov, S. V., and Perevozchikov, A. P. (2010) PPARgamma activates ABCA1 gene transcription but reduces the level of ABCA1 protein in HepG2 cells. Biochem. Biophys. Res. Commun. 402, 477-482
19. Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., and Speleman, F. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, research0034
20. Hozoji, M., Munehira, Y., Ikeda, Y., Makishima, M., Matsuo, M., Kioka, N., and Ueda, K. (2008) Direct interaction of nuclear liver X receptor-beta with ABCA1 modulates cholesterol efflux. J. Biol. Chem. 283, 30057-30063
21. Tedla, N., Glaros, E. N., Brunk, U. T., Jessup, W., and Garner, B. (2004) Heterogeneous expression of apolipoprotein-E by human macrophages. Immunology 113, 338-347 (Pubitemid 39472150)
22. Chroni, A., Liu, T., Fitzgerald, M. L., Freeman, M. W., and Zannis, V. I. (2004) Cross-linking and lipid efflux properties of apoA-I mutants suggest direct association between apoA-I helices and ABCA1. Biochemistry 43, 2126-2139 (Pubitemid 38233274)
23. Wang, N., Silver, D. L., Costet, P., and Tall, A. R. (2000) Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J. Biol. Chem. 275, 33053-33058
24. Arakawa, R., and Yokoyama, S. (2002) Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation. J. Biol. Chem. 277, 22426-22429 (Pubitemid 34967213)
25. Gaus, K., Kritharides, L., Schmitz, G., Boettcher, A., Drobnik, W., Langmann, T., Quinn, C. M., Death, A., Dean, R. T., and Jessup, W. (2004) Apolipoprotein A-1 interaction with plasma membrane lipid rafts controls cholesterol export from macrophages. FASEB J. 18, 574-576
26. Tang, T., Liu, Y., Kessler, P. S., Vaughan, A. M., and Oram, J. F. (2009) The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor. J. Biol. Chem. 284, 32336-32343
27. Suzuki, M., Pritchard, D. K., Becker, L., Hoofnagle, A. N., Tanimura, N., Bammler, T. K., Beyer, R. P., Bumgarner, R., Vaisar, T., de Beer, M. C., de Beer, F. C., Miyake, K., Oram, J. F., and Heinecke, J. W. (2010) High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide. Circulation 122, 1919 -1927
28. Song, H., Saito, K., Fujigaki, S., Noma, A., Ishiguro, H., Nagatsu, T., and Seishima, M. (1998) IL-1 beta and TNF-alpha suppress apolipoprotein (apo) E secretion and apo A-I expression in HepG2 cells. Cytokine 10, 275-280 (Pubitemid 28227070)
29. Orlov, S. V., Mogilenko, D. A., Shavva, V. S., Dizhe, E. B., Ignatovich, I. A., and Perevozchikov, A. P. (2010) Effect of TNFalpha on activities of different promoters of human apolipoprotein A-I gene. Biochem. Biophys. Res. Commun. 398, 224 -230
30. Duan, H., Li, Z., and Mazzone, T. (1995) Tumor necrosis factor-alpha modulates monocyte/macrophage apoprotein E gene expression. J. Clin. Invest. 96, 915-922
31. Wang, X., and Rader, D. J. (2007) Molecular regulation of macrophage reverse cholesterol transport. Curr. Opin. Cardiol. 22, 368-372 (Pubitemid 46897290)
32. Oram, J. F. (2003) HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol. Arterioscler. Thromb. Vasc. Biol. 23, 720-727
33. Rye, K. A., and Barter, P. J. (2008) Antiinflammatory actions of HDL: a new insight. Arterioscler. Thromb. Vasc. Biol. 28, 1890-1891
34. Wu, A. L., and Windmueller, H. G. (1979) Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat. J. Biol. Chem. 254, 7316-7322 (Pubitemid 9241815)
35. Doherty, N. S., Littman, B. H., Reilly, K., Swindell, A. C., Buss, J. M., and Anderson, N. L. (1998) Analysis of changes in acute-phase plasma proteins in an acute inflammatory response and in rheumatoid arthritis using two-dimensional gel electrophoresis. Electrophoresis 19, 355-363 (Pubitemid 28131263)
36. Bresnihan, B., Gogarty, M., Fitzgerald, O., Dayer, J.-M., and Burger, D. (2004) Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: a control mechanism of cytokine production? Arthritis. Res. Ther. 6, R563-R566
37. Feig, J. E., Rong, J. X., Shamir, R., Sanson, M., Vengrenyuk, Y., Liu, J., Rayner, K., Moore, K., Garabedian, M., Fisher, E. A. (2011) HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. Proc. Natl. Acad. Sci. U. S. A. 108, 7166 -7171
38. Murphy, A. J., Woollard, K. J., Hoang, A., Mukhamedova, N., Stirzaker, R. A., McCormick, S. P., Remaley, A. T., Sviridov, D., and Chin-Dusting, J. (2008) High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler. Thromb. Vasc. Biol. 28, 2071-2077
39. Zhu, X., Owen, J. S., Wilson, M. D., Li, H., Griffiths, G. L., Thomas, M. J., Hiltbold, E. M., Fessler, M. B., and Parks, J. S. (2010) Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J. Lipid Res. 51, 3196-3206
40. Zhu, X., Lee, J. Y., Timmins, J. M., Brown, J. M., Boudyguina, E., Mulya, A., Gebre, A. K., Willingham, M. C., Hiltbold, E. M., Mishra, N., Maeda, N., and Parks, J. S. (2008) Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J. Biol. Chem. 283, 22930-22941